HAE is usually caused by genetic variants affecting C1 esterase inhibitor (C1-INH); deficient or dysfunctional C1-INH leads to unrestrained activation of the kallikrein-kinin system, resulting in augmented bradykinin levels, vascular permeability, and localized swelling [6, 7]. The gene discussed is SERPING1; the disease is hereditary angioedema.